Skip to main content

Common variation in Nemo-like kinase is associated with risk of ovarian cancer.

Publication ,  Journal Article
Stevens, KN; Kelemen, LE; Wang, X; Fridley, BL; Vierkant, RA; Fredericksen, Z; Armasu, SM; Tsai, Y-Y; Berchuck, A; Narod, SA; Phelan, CM ...
Published in: Cancer Epidemiol Biomarkers Prev
March 2012

BACKGROUND: Overexpression of mitotic kinases has been associated with prognosis, histologic grade, and clinical stage in ovarian cancer, but the relationship between inherited variation in these genes and ovarian cancer risk has not been well defined. METHODS: We measured associations between 397 single nucleotide polymorphisms (SNPs) from 67 mitotic kinases and invasive epithelial ovarian cancer risk in two case-control studies (n = 671 cases; n = 939 controls). Thirty-six candidate SNPs (P < 0.05) were assessed in a replication analysis consisting of three additional studies (n = 1,094 cases; n = 829 controls). RESULTS: In initial analysis, thirty-six SNPs were suggestive of association with risk of serous ovarian cancer, all subtypes of ovarian cancer, or both (P < 0.05). Replication analyses suggested an association between rs2125846 in the Nemo-like kinase (NLK) gene and ovarian cancer (serous OR = 1.36, 95% CI: 1.11-1.67, P = 1.77 × 10(-3); all subtypes OR = 1.30, 95% CI: 1.08-1.56, P = 2.97 × 10(-3)). Furthermore, rs2125846 was associated with risk in the combined discovery and replication sets (serous OR = 1.33, 95% CI: 1.15-1.54; all subtypes OR = 1.27, 95% CI: 1.12-1.45). CONCLUSIONS: Variation in NLK may be associated with risk of invasive epithelial ovarian cancer. Further studies are needed to confirm and understand the biologic relationship between this mitotic kinase and ovarian cancer risk. IMPACT: An association between SNPs in NLK and ovarian cancer may provide biologic insight into the development of this disease.

Duke Scholars

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

March 2012

Volume

21

Issue

3

Start / End Page

523 / 528

Location

United States

Related Subject Headings

  • Risk Factors
  • Protein Serine-Threonine Kinases
  • Prognosis
  • Polymorphism, Single Nucleotide
  • Polymerase Chain Reaction
  • Ovarian Neoplasms
  • Neoplasm Invasiveness
  • Mitosis
  • Intracellular Signaling Peptides and Proteins
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stevens, K. N., Kelemen, L. E., Wang, X., Fridley, B. L., Vierkant, R. A., Fredericksen, Z., … Couch, F. J. (2012). Common variation in Nemo-like kinase is associated with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev, 21(3), 523–528. https://doi.org/10.1158/1055-9965.EPI-11-0797
Stevens, Kristen N., Linda E. Kelemen, Xianshu Wang, Brooke L. Fridley, Robert A. Vierkant, Zachary Fredericksen, Sebastian M. Armasu, et al. “Common variation in Nemo-like kinase is associated with risk of ovarian cancer.Cancer Epidemiol Biomarkers Prev 21, no. 3 (March 2012): 523–28. https://doi.org/10.1158/1055-9965.EPI-11-0797.
Stevens KN, Kelemen LE, Wang X, Fridley BL, Vierkant RA, Fredericksen Z, et al. Common variation in Nemo-like kinase is associated with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):523–8.
Stevens, Kristen N., et al. “Common variation in Nemo-like kinase is associated with risk of ovarian cancer.Cancer Epidemiol Biomarkers Prev, vol. 21, no. 3, Mar. 2012, pp. 523–28. Pubmed, doi:10.1158/1055-9965.EPI-11-0797.
Stevens KN, Kelemen LE, Wang X, Fridley BL, Vierkant RA, Fredericksen Z, Armasu SM, Tsai Y-Y, Berchuck A, Narod SA, Phelan CM, Sutphen R, Birrer MJ, Schildkraut JM, Sellers TA, Goode EL, Ovarian Cancer Association Consortium, Couch FJ. Common variation in Nemo-like kinase is associated with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):523–528.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

March 2012

Volume

21

Issue

3

Start / End Page

523 / 528

Location

United States

Related Subject Headings

  • Risk Factors
  • Protein Serine-Threonine Kinases
  • Prognosis
  • Polymorphism, Single Nucleotide
  • Polymerase Chain Reaction
  • Ovarian Neoplasms
  • Neoplasm Invasiveness
  • Mitosis
  • Intracellular Signaling Peptides and Proteins
  • Humans